Baicheng Pharmaceutical: Announcement on the 2022 Restricted Stock Incentive Plan for Cancelled Companies Partially Granted Restricted Shares Not Owned
Baicheng Pharmaceutical: Announcement on the achievement of the vesting conditions for the first time and the second reserved portion of the 2022 Restricted Stock Incentive Plan
Baicheng Pharmaceutical: Announcement on Adjusting the Price Granted by the Company\'s 2022 Restricted Stock Incentive Plan
Baicheng Pharmaceutical: Supervisory Board\'s Review of the Vesting List for the First Time and Second Reserved Part of the 2022 Restricted Stock Incentive Plan
Hangzhou Bio-Sincerity Pharma-Tech: 2023 Annual Equity Distribution Implementation Notice
Baicheng Pharmaceutical: Hangzhou Baicheng Pharmaceutical Technology Co., Ltd. shareholder dividend return plan for the next three years (2024-2026)
Baicheng Pharmaceutical: Announcement on the Company's 2023 Profit Distribution Plan
Baicheng Pharmaceutical: Announcement on the completion of the implementation of share repurchases and changes in shares
Baicheng Pharmaceutical: Announcement on the progress of the repurchase of the company\'s shares
Baicheng Pharmaceutical: Announcement on the progress of the repurchase of the company\'s shares
Baicheng Pharmaceutical: Announcement on the results of the initial vesting period of the 2022 Restricted Stock Incentive Plan and the initial vesting period of the reserved portion and the stock listing
Baicheng Pharmaceutical: Announcement on the progress of the repurchase of the company\'s shares
Baicheng Pharmaceutical: Audit opinion of the Board of Supervisors on the first and part of the first vesting period of the 2022 Restricted Stock Incentive Plan
Baicheng Pharmaceutical: Notice on Cancelling Part of the Company\'s 2022 Restricted Stock Incentive Plan that has already been granted restricted shares that have not yet been owned
Baicheng Pharmaceutical: 2023-036 Announcement on the fulfillment of the conditions for the first and first vesting periods of the 2022 Restricted Stock Incentive Plan
Baicheng Pharmaceutical: Beijing Hairun Tianrui Law Firm\'s legal opinion on price adjustments granted by Hangzhou Baicheng Pharmaceutical Technology Co., Ltd.\'s 2022 restricted stock incentive plan, fulfillment of the conditions for the first period of o
Baicheng Pharmaceutical: Shanghai Xingong Yihe Enterprise Management Consulting Co., Ltd.\'s independent financial advisory report on matters relating to the first restricted stock incentive plan of Hangzhou Baicheng Pharmaceutical Technology Co., Ltd. and
Baicheng Pharmaceutical: Notice on Adjusting the Grant Price of the Company\'s 2022 Restricted Stock Incentive Plan
Baicheng Pharmaceutical: Announcement on the initial repurchase of the company\'s shares
Baicheng Pharmaceutical: Repurchase Report
No Data
No Data